Does HUMAN IMMUNOGLOBULIN G Cause Poor venous access? 504 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 504 reports of Poor venous access have been filed in association with HUMAN IMMUNOGLOBULIN G (BIVIGAM). This represents 0.7% of all adverse event reports for HUMAN IMMUNOGLOBULIN G.
504
Reports of Poor venous access with HUMAN IMMUNOGLOBULIN G
0.7%
of all HUMAN IMMUNOGLOBULIN G reports
18
Deaths
199
Hospitalizations
How Dangerous Is Poor venous access From HUMAN IMMUNOGLOBULIN G?
Of the 504 reports, 18 (3.6%) resulted in death, 199 (39.5%) required hospitalization, and 9 (1.8%) were considered life-threatening.
Is Poor venous access Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN IMMUNOGLOBULIN G. However, 504 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN IMMUNOGLOBULIN G Cause?
Headache (7,885)
Off label use (5,872)
Fatigue (5,423)
Nausea (4,454)
Sinusitis (4,409)
Pyrexia (4,076)
Drug ineffective (3,923)
Pruritus (3,775)
Dyspnoea (3,518)
Malaise (3,180)
What Other Drugs Cause Poor venous access?
VEDOLIZUMAB (1,043)
INFLIXIMAB (917)
INFLIXIMAB-DYYB (782)
ECULIZUMAB (555)
NATALIZUMAB (422)
RITUXIMAB (299)
TOCILIZUMAB (287)
METHOTREXATE (257)
ABATACEPT (249)
IDURSULFASE (175)
Which HUMAN IMMUNOGLOBULIN G Alternatives Have Lower Poor venous access Risk?
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMAN IMMUNOGLOBULIN G vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMAN IMMUNOGLOBULIN G vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMAN IMMUNOGLOBULIN G vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
HUMAN IMMUNOGLOBULIN G vs HUMAN RHO IMMUNE GLOBULIN